04/26/2024 4:22 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 4:18 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 4:20 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:57 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 4:59 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 5:01 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 5:05 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/19/2024 5:06 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:18 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:14 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2024 3:16 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:54 PM | Fromkin Andrew J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:31 PM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:34 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:37 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:39 PM | Immunovant (Issuer) Stout Jay S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:44 PM | Immunovant (Issuer) Torti Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:46 PM | Immunovant (Issuer) Pande Atul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:48 PM | Immunovant (Issuer) MIGAUSKY GEORGE V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:50 PM | Hughes Douglas J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:23 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:27 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:29 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:14 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:16 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:18 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 3:21 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:47 AM | Deep Track Capital, LP (Filed by) Immunovant (Subject)
| Form SC 13G/A | |
02/12/2024 6:02 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 6:05 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
02/09/2024 8:16 AM | Immunovant (Subject)
| Form SC 13G | |
01/19/2024 3:04 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 6:29 AM | Geffner Michael (Reporting) Immunovant (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/12/2024 3:34 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:18 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 3:20 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 7:08 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2023 3:37 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 3:25 PM | Immunovant (Issuer) MIGAUSKY GEORGE V (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:28 PM | Immunovant (Issuer) Pande Atul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:30 PM | Fromkin Andrew J. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Buy this small stock before coming AI Tidal Wave (Ad) The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone.
Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=7620&Placement=NativeDisplay&Source=NativeDisplay) Get the name and ticker symbol for free - just click here. |
12/01/2023 3:19 PM | Immunovant (Subject) MIGAUSKY GEORGE V (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:19 PM | Fromkin Andrew J. (Reporting) Immunovant (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:20 PM | Immunovant (Subject) Pande Atul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/28/2023 6:43 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/24/2023 1:55 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:45 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:47 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:51 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/24/2023 1:41 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/09/2023 7:49 AM | Immunovant (Filer)
| Form S-3ASR | |
11/09/2023 6:06 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:13 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/20/2023 3:06 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2023 3:11 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 4:10 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/06/2023 4:15 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 4:15 PM | Immunovant (Issuer) Roivant Sciences Ltd. (Reporting) Roivant Sciences Ltd. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 4:19 PM | Immunovant (Subject) Roivant Sciences Ltd. (Filed by) Roivant Sciences Ltd. (Filed by)
| Form SC 13D/A | |
09/29/2023 3:48 PM | Immunovant (Filer)
| Form 424B5 | |
09/28/2023 4:23 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/28/2023 5:09 AM | Immunovant (Subject)
| Form FWP | |
09/26/2023 7:00 PM | Immunovant (Subject)
| Form FWP | |
09/26/2023 4:28 PM | Immunovant (Filer)
| Form 424B5 | |
09/26/2023 6:45 AM | Immunovant (Filer) Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 4:00 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 4:03 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 4:05 PM | Immunovant (Issuer) Levine Mark S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2023 3:57 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 3:48 PM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/16/2023 3:11 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/10/2023 6:19 AM | Immunovant (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 6:10 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/20/2023 3:35 PM | Barnett Eva Renee (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/20/2023 3:37 PM | Immunovant (Issuer) Macias William L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 4:10 PM | Butchko Julia G. (Reporting) Immunovant (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/13/2023 4:11 PM | Immunovant (Issuer) Salzmann Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2023 6:35 AM | Immunovant (Filer)
| Form DEFA14A | |
06/26/2023 6:26 AM | Immunovant (Filer)
| Form DEF 14A | |
05/22/2023 6:03 AM | Immunovant (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/22/2023 6:10 AM | Immunovant (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |